F16.1

Clinical Causes: Use of hallucinogenic substances such as LSD, psilocybin mushrooms, mescaline, or DMT Recreational experimentation without awareness of risks Psychological factors like curiosity, peer pressure, or mental health issues Previous substance abuse history that escalates to hallucinogen misuse Availability and accessibility of hallucinogenic drugs

Key Symptoms: Altered perceptions and intense sensory experiences Visual or auditory hallucinations Distorted sense of time and space Mood swings, including euphoria or anxiety Impaired judgment and confusion Dilated pupils and increased heart rate Nausea or dizziness Paranoia or panic attacks during or after substance use Flashbacks or recurrence of hallucinations after drug effects have worn off

Diagnosis Path: Diagnosis of hallucinogen abuse typically involves a combination of clinical assessment and patient history. Healthcare providers look for signs of problematic substance use, behavioral changes, and physical symptoms consistent with hallucinogen effects. Screening tools and neurological examinations may be used to rule out other conditions. It is also important to evaluate for co-occurring mental health disorders, such as anxiety or depression, which often accompany substance misuse.

Treatment Protocols: Managing hallucinogen abuse involves a comprehensive approach including behavioral therapies, counseling, and support groups. There are no specific medications approved solely for treating hallucinogen dependence, but addressing associated mental health issues can be beneficial. Treatment strategies focus on stabilizing the individual, preventing relapse, and providing education about substance risks. In some cases, hospitalization may be necessary for severe psychological effects or overdose management.